此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Polypropylene Versus Polyglactin in Upper Limb Subcuticular Skin Closure

2026年5月11日 更新者:Mohamed Elsaid Hamisa、Shebin El-Kom Teaching Hospital

Polypropylene Versus Polyglactin in Upper Limb Subcuticular Skin Closure: Results From a Randomized Controlled Trial.

Polypropylene versus Polyglactin in Upper Limb Subcuticular Skin Closure

研究概览

详细说明

Background and Rationale Although previous studies have compared absorbable and non-absorbable sutures, most did not specifically evaluate standardized scar outcomes for subcuticular closure in the upper limb. While upper limb wounds may not carry the same aesthetic priority as facial wounds, scars in this region are highly visible and can adversely affect patients' psychological well-being. Subcuticular suturing is commonly used to improve cosmetic outcomes and reduce wound complications. Both Polypropylene (non-absorbable) and Polyglactin (absorbable) are widely used materials, yet their comparative performance in subcuticular skin closure remains controversial.

Aim and Objectives

Primary objective:

- To compare cosmetic outcomes of subcuticular skin closure using Polypropylene and Polyglactin

Secondary objectives:

  • To compare postoperative wound complication rates (including infection, wound dehiscence, and hematoma formation) between polypropylene and polyglactin sutures
  • To assess patient-reported discomfort and satisfaction associated with each suture material
  • To assess the influence of the nature of surgery (elective vs trauma) on wound healing outcomes for each suture type

研究类型

介入性

注册 (估计的)

100

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

      • Menoufia Governorate、埃及、33511
        • 招聘中
        • Shebin El Koum teaching Hospital
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Adults aged ≥18 years
  • Patients undergoing any surgical procedure involving the upper limb
  • Procedures performed in either elective or emergency settings
  • Wounds suitable for primary subcuticular skin closure
  • Ability to provide informed consent

Exclusion Criteria:

  • Heavily contaminated or infected wounds
  • Patients with uncontrolled diabetes mellitus, chronic steroid use, immunosuppression or peripheral vascular disease
  • Crush injuries and wounds with significant tissue loss
  • Known allergy to suture material
  • Delayed primary closure wounds

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Cosmetic outcome measured using the Patient and Observer Scar Assessment Scale (POSAS) total score (range 6-60)
大体时间:Baseline
Scar quality will be evaluated using the Patient and Observer Scar Assessment Scale (POSAS), which includes both patient-reported and observer-reported components. Each item is scored from 1 to 10, with total scores ranging from 6 to 60, where lower scores indicate better cosmetic outcome.
Baseline

次要结果测量

结果测量
措施说明
大体时间
Incidence of surgical site infection (SSI) (number and percentage of patients)
大体时间:Baseline
Surgical site infection will be assessed based on clinical criteria including the presence of purulent discharge, localized swelling, erythema, warmth, or wound dehiscence, with or without positive bacterial culture. The outcome will be reported as the number and percentage of patients who develop SSI during the follow-up period.
Baseline
Incidence of wound dehiscence (number and percentage of patients)
大体时间:Baseline
Wound dehiscence will be defined as partial or complete separation of the surgical wound edges after closure. The outcome will be assessed clinically during follow-up visits and reported as the number and percentage of patients who develop wound dehiscence.
Baseline
Incidence of hematoma formation (number and percentage of patients)
大体时间:Baseline
Hematoma formation will be defined as a localized collection of blood at the surgical site, identified clinically by swelling, discoloration, or tension, with or without the need for evacuation. The outcome will be assessed during follow-up and reported as the number and percentage of patients who develop a hematoma.
Baseline
Patient satisfaction measured using a 5-point Likert scale (score range 1-5)
大体时间:Baseline
Patient satisfaction will be assessed using a 5-point Likert scale, where 1 indicates very dissatisfied and 5 indicates very satisfied. The outcome will be reported as a numerical score reflecting the patient's overall satisfaction with the surgical result.
Baseline

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年5月1日

初级完成 (估计的)

2027年5月1日

研究完成 (估计的)

2027年11月1日

研究注册日期

首次提交

2026年4月21日

首先提交符合 QC 标准的

2026年5月11日

首次发布 (实际的)

2026年5月13日

研究记录更新

最后更新发布 (实际的)

2026年5月13日

上次提交的符合 QC 标准的更新

2026年5月11日

最后验证

2026年5月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 共享支持信息类型

  • 研究方案
  • 国际碳纤维联合会

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅